, Tracking Stock Market Picks
Enter Symbol:
Enanta Pharmaceuticals Inc. (ENTA) [hlAlert]

up 105.22 %

Enanta Pharmaceuticals Inc. (ENTA) rated Outperform by Credit Suisse

Posted on: Monday,  Apr 15, 2013  8:25 AM ET by Credit Suisse

Credit Suisse rated Outperform Enanta Pharmaceuticals Inc. (NASDAQ: ENTA) on 04/15/2013, when the stock price was $20.48. Since
then, Enanta Pharmaceuticals Inc. has gained 105.22% as of 01/27/2016's recent price of $42.03.
If you would have followed this Credit Suisse's recommendation on ENTA, you would have gained 105.22% of your investment in 1017 days.

Excellence in equity and fixed income research is a hallmark of Credit Suisse. Globally, our equity research analysts provide in-depth coverage of over 2,500 companies and engage in a knowledge-sharing, value added culture that has yielded the most insightful product for our customers and tremendous competitive results. Additionally, Credit Suisse's powerful macro-economic and debt strategy teams integrate the bank's comprehensive company research with keen market perspectives of the ever-shifting investment terrain.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
4/15/2013 8:25 AM Buy
as of 12/13/2013
1 Week up  34.05 %
1 Month up  82.33 %
3 Months up  94.65 %
1 YTD up  81.44 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy